---
input_text: 'Wilson Disease: Diagnosis, Treatment, and Follow-up. Consideration of
  a diagnosis of Wilson disease is still the critical factor in testing for and establishing
  disease diagnosis. In association with other clinical and biochemical tests, liver
  biopsy results and molecular genetic testing can also be used to generate a score
  for diagnosing Wilson disease. Medical therapy is effective for most patients; liver
  transplant can rescue those with acute liver failure or those with advanced liver
  disease who fail to respond to or discontinue medical therapy. Treatment monitoring
  must be done at regular intervals and includes clinical evaluation, liver tests
  and blood counts, and copper metabolic parameters.'
raw_completion_output: |-
  primary_disease: Wilson Disease

  medical_actions: liver biopsy; molecular genetic testing; medical therapy; liver transplant; treatment monitoring; clinical evaluation; liver tests; blood counts; copper metabolic parameters assessment

  symptoms: acute liver failure; advanced liver disease

  chemicals: 

  action_annotation_relationships: liver biopsy TREATS diagnosis uncertainty IN Wilson Disease; molecular genetic testing TREATS diagnosis uncertainty IN Wilson Disease; medical therapy TREATS acute liver failure IN Wilson Disease; medical therapy TREATS advanced liver disease IN Wilson Disease; liver transplant TREATS acute liver failure IN Wilson Disease; liver transplant TREATS advanced liver disease IN Wilson Disease; treatment monitoring TREATS acute liver failure IN Wilson Disease; treatment monitoring TREATS advanced liver disease IN Wilson Disease; clinical evaluation TREATS acute liver failure IN Wilson Disease; clinical evaluation TREATS advanced liver disease IN Wilson Disease; liver tests TREATS acute liver failure IN Wilson Disease; liver tests TREATS advanced liver disease IN Wilson Disease; blood counts TREATS acute liver failure IN Wilson Disease; blood counts TREATS advanced liver disease IN Wilson Disease; copper metabolic parameters assessment TREATS acute liver failure IN Wilson Disease; copper metabolic parameters assessment TREATS advanced liver disease IN Wilson Disease
prompt: |+
  From the text below, extract the following entities in the following format:

  subject_extension: <A chemical or drug mentioned in the relationship between the medical action and the symptom, for example, "analgesic agent therapy" has the aspect "analgesic">
  object_extension: <An optional term describing some specific aspect of the object, e.g. "analgesic agent therapy" has the aspect "analgesic">
  subject: <The medical action. For example: blood transfusion, radiation therapy, cardiac catheterization, pulse oximetry, otoscopy>
  predicate: <The relationship type between the medical action and the symptom, usually TREATS or PREVENTS.>
  object: <A sign or symptom associated with the disease and targeted by the medical action. For example, Low serum calcitriol, hypoplasia of the thymus, chronic cough, aortic stiffness, low pulse pressure>
  qualifier: <The primary disease the relationship is about, or specifically the disease the symptom is related to. For example, Beck-Fahrner syndrome, hereditary retinoblastoma, progeria, diabetes mellitus, infectious otitis media>
  subject_qualifier: <An optional qualifier or modifier for the subject of the statement, e.g. "high dose" or "intravenously administered">
  object_qualifier: <An optional qualifier or modifier for the object of the statement, e.g. "severe" or "with additional complications">


  Text:
  copper metabolic parameters assessment TREATS advanced liver disease IN Wilson Disease

  ===

extracted_object:
  primary_disease: MONDO:0010200
  medical_actions:
    - MAXO:0000376
    - MAXO:0000533
    - medical therapy
    - liver transplant
    - treatment monitoring
    - clinical evaluation
    - liver tests
    - blood counts
    - copper metabolic parameters assessment
  symptoms:
    - HP:0006554
    - advanced liver disease
  action_annotation_relationships:
    - subject: MAXO:0000376
      predicate: TREATS
      object: diagnosis uncertainty
      qualifier: MONDO:0010200
    - subject: MAXO:0000533
      predicate: TREATS
      object: diagnosis uncertainty
      qualifier: MONDO:0010200
    - subject: medical therapy
      predicate: TREATS
      object: HP:0006554
      qualifier: MONDO:0010200
    - subject: medical therapy
      predicate: TREATS
      object: advanced liver disease
      qualifier: MONDO:0010200
    - subject: liver transplant
      predicate: TREATS
      object: HP:0006554
      qualifier: MONDO:0010200
    - subject: <liver transplant>
      predicate: <TREATS>
      object: <advanced liver disease>
      qualifier: <Wilson Disease>
      subject_qualifier: <>
      object_qualifier: <>
      subject_extension: <liver transplant>
      object_extension: <advanced liver disease>
    - subject: treatment monitoring
      predicate: TREATS
      object: HP:0006554
      qualifier: MONDO:0010200
    - subject: treatment monitoring
      predicate: TREATS
      object: advanced liver disease
      qualifier: MONDO:0010200
    - subject: clinical evaluation
      predicate: TREATS
      object: HP:0006554
      qualifier: MONDO:0010200
    - subject: clinical evaluation
      predicate: TREATS
      object: advanced liver disease
      qualifier: MONDO:0010200
    - subject: liver tests
      predicate: TREATS
      object: HP:0006554
      qualifier: MONDO:0010200
    - subject: liver tests
      predicate: TREATS
      object: advanced liver disease
      qualifier: MONDO:0010200
    - subject: blood counts
      predicate: TREATS
      object: HP:0006554
      qualifier: MONDO:0010200
    - subject: blood counts
      predicate: TREATS
      object: advanced liver disease
      qualifier: MONDO:0010200
    - subject: copper metabolic parameters assessment
      predicate: TREATS
      object: HP:0006554
      qualifier: MONDO:0010200
      subject_extension: copper metabolic parameters assessment
    - subject: copper metabolic parameters assessment
      predicate: TREATS
      object: advanced liver disease
      qualifier: MONDO:0010200
      subject_extension: copper metabolic parameters assessment
named_entities:
  - id: MONDO:0010200
    label: Wilson's disease
  - id: MAXO:0001175
    label: Liver transplantation
  - id: HP:0001695
    label: Cardiac arrest
  - id: HP:0001685
    label: Myocardial fibrosis
  - id: HP:0001663
    label: Ventricular fibrillation
  - id: CHEBI:28694
    label: Copper
  - id: CHEBI:18248
    label: Iron
  - id: HP:0002910
    label: abnormal liver functions
  - id: HP:0001394
    label: cirrhosis
  - id: CHEBI:27363
    label: zinc
  - id: CHEBI:50868
    label: penicillamine
  - id: MAXO:0000016
    label: Cell therapy
  - id: MAXO:0001001
    label: Gene therapy
  - id: CHEBI:30703
    label: Tetrathiomolybdate (TTM)
  - id: HP:0006554
    label: acute liver failure
  - id: CHEBI:35176
    label: Zinc sulphate
  - id: CHEBI:35475
    label: NSAIDs
  - id: MAXO:0009095
    label: zinc therapy
  - id: MAXO:0001298
    label: therapy
  - id: HP:0006579
    label: neonatal jaundice
  - id: HP:0001409
    label: portal hypertension
  - id: HP:0030151
    label: cholangitis
  - id: HP:0002612
    label: congenital hepatic fibrosis
  - id: MONDO:0013282
    label: alpha-1-antitrypsin deficiency
  - id: HP:0001903
    label: anemia
  - id: HP:0001410
    label: liver dysfunction
  - id: CHEBI:39501
    label: trientine
  - id: MAXO:0000070
    label: Hepatic transplantation
  - id: HP:0001399
    label: Hepatic failure
  - id: HP:0004448
    label: fulminant hepatic failure
  - id: HP:0003256
    label: coagulopathy (international normalized ratio >2.0)
  - id: HP:0004445
    label: hepatic encephalopathy (HE)
  - id: HP:0002480
    label: hepatic encephalopathy
  - id: CHEBI:35341
    label: Steroids
  - id: CHEBI:33281
    label: Antibiotics
  - id: MONDO:0100193
    label: End-stage liver disease
  - id: HP:0100626
    label: End-stage liver disease
  - id: HP:0100660
    label: dyskinesia
  - id: HP:0100022
    label: Movement disorders
  - id: HP:0001337
    label: Tremor
  - id: HP:0001332
    label: Dystonia
  - id: MONDO:0019542
    label: Acute liver failure (ALF)
  - id: CHEBI:27385
    label: CCL4
  - id: MAXO:0000127
    label: Genetic testing
  - id: CHEBI:7959
    label: D-penicillamine
  - id: MAXO:0001017
    label: Vaccination
  - id: HP:0001541
    label: Ascites
  - id: HP:0012398
    label: Peripheral edema
  - id: HP:0001260
    label: dysarthria
  - id: HP:0000708
    label: psychiatric disorders
  - id: HP:0200123
    label: chronic hepatitis
  - id: CHEBI:38161
    label: chelators
  - id: MAXO:0000376
    label: liver biopsy
  - id: HP:0001404
    label: hepatocellular necrosis
  - id: CHEBI:61049
    label: Tacrolimus
  - id: HP:0001744
    label: Splenomegaly
  - id: MAXO:0000603
    label: Peritoneal dialysis
  - id: HP:0200032
    label: Kayser-Fleischer rings
  - id: HP:0002172
    label: impaired balance
  - id: HP:0001347
    label: hyperreflexia
  - id: HP:0031843
    label: bradyphrenia
  - id: HP:0002362
    label: shuffling gait
  - id: HP:0001621
    label: hypophonia
  - id: CHEBI:37153
    label: Calcineurin inhibitors
  - id: CHEBI:8356
    label: pramipexole
  - id: CHEBI:2618
    label: amantadine
  - id: HP:0000093
    label: proteinuria
  - id: CHEBI:231592
    label: zinc salts
  - id: MAXO:0000167
    label: antiepileptic therapy
  - id: CHEBI:9168
    label: rapamycin
  - id: CHEBI:55379
    label: cyclosporine (CsA)
  - id: CHEBI:35623
    label: antiepileptic
  - id: HP:0000083
    label: renal failure
  - id: HP:0000952
    label: jaundice
  - id: HP:0001919
    label: acute kidney injury
  - id: HP:0001342
    label: intracerebral hemorrhage
  - id: MAXO:0000533
    label: molecular genetic testing
